BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith BAH, Bertozzi CR. The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans. Nat Rev Drug Discov 2021;20:217-43. [PMID: 33462432 DOI: 10.1038/s41573-020-00093-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Marcelo F, Nativi C, Russo L, Silipo A, Velasco-Torrijos T. Editorial: Glyco-Tools to Crack Unsolved Biomedical Needs. Front Chem 2021;9:789839. [PMID: 34869237 DOI: 10.3389/fchem.2021.789839] [Reference Citation Analysis]
2 Mao C, Zhuang S, Xia Z, Xiao Z, Huang C, Su Q, Chen J, Liao J. Pan‐cancer analysis of GALNTs expression identifies a prognostic of GALNTs feature in low grade glioma. J Leukocyte Bio. [DOI: 10.1002/jlb.5ma1221-468r] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lamprinaki D, Garcia-Vello P, Marchetti R, Hellmich C, McCord KA, Bowles KM, Macauley MS, Silipo A, De Castro C, Crocker PR, Juge N. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis. Front Immunol 2021;12:744184. [PMID: 34659241 DOI: 10.3389/fimmu.2021.744184] [Reference Citation Analysis]
4 Xu Z, Deng Y, Zhang Z, Ma W, Li W, Wen L, Li T. Diversity-Oriented Chemoenzymatic Synthesis of Sulfated and Nonsulfated Core 2 O-GalNAc Glycans. J Org Chem 2021;86:10819-28. [PMID: 34254798 DOI: 10.1021/acs.joc.1c01115] [Reference Citation Analysis]
5 Li P, Pang J, Xu S, He H, Ma Y, Liu Z. A Glycoform‐Resolved Dual‐Modal Ratiometric Immunoassay Improves the Diagnostic Precision for Hepatocellular Carcinoma. Angewandte Chemie 2022;134. [DOI: 10.1002/ange.202113528] [Reference Citation Analysis]
6 Milošević N, Rütter M, David A. Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines. Front Med Technol 2022;4:846065. [DOI: 10.3389/fmedt.2022.846065] [Reference Citation Analysis]
7 Sigal DS, Hermel DJ, Hsu P, Pearce T. The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets. Future Oncol 2022;18:117-34. [PMID: 34734786 DOI: 10.2217/fon-2021-1110] [Reference Citation Analysis]
8 Liu D, Duan L, Cyster JG. Chemo- and mechanosensing by dendritic cells facilitate antigen surveillance in the spleen. Immunol Rev 2022;306:25-42. [PMID: 35147233 DOI: 10.1111/imr.13055] [Reference Citation Analysis]
9 Conroy LR, Hawkinson TR, Young LEA, Gentry MS, Sun RC. Emerging roles of N-linked glycosylation in brain physiology and disorders. Trends Endocrinol Metab 2021;32:980-93. [PMID: 34756776 DOI: 10.1016/j.tem.2021.09.006] [Reference Citation Analysis]
10 Mai S, Inkielewicz-Stepniak I. Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target. Front Cell Dev Biol 2021;9:749689. [PMID: 34858977 DOI: 10.3389/fcell.2021.749689] [Reference Citation Analysis]
11 Blšákova A, Květoň F, Lorencová L, Blixt O, Vikartovská A, Kasak P, Tkac J. Amplified suspension magnetic bead-based assay for sensitive detection of anti-glycan antibodies as potential cancer biomarkers. Analytica Chimica Acta 2022;1195:339444. [DOI: 10.1016/j.aca.2022.339444] [Reference Citation Analysis]
12 Jennings EQ, Fritz KS, Galligan JJ. Biochemical genesis of enzymatic and non-enzymatic post-translational modifications. Mol Aspects Med 2021;:101053. [PMID: 34838336 DOI: 10.1016/j.mam.2021.101053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Moons SJ, Rossing E, Janssen MACH, Heise T, Büll C, Adema GJ, Boltje TJ. Structure-Activity Relationship of Metabolic Sialic Acid Inhibitors and Labeling Reagents. ACS Chem Biol 2022;17:590-7. [PMID: 35179348 DOI: 10.1021/acschembio.1c00868] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cao X, Cordova AF, Li L. Therapeutic Interventions Targeting Innate Immune Receptors: A Balancing Act. Chem Rev 2021. [PMID: 34870969 DOI: 10.1021/acs.chemrev.1c00716] [Reference Citation Analysis]
15 Russo L. Glycans and diagnostics in nanomedicine. Nanomedicine (Lond) 2021;16:1839-42. [PMID: 34348476 DOI: 10.2217/nnm-2021-0173] [Reference Citation Analysis]
16 Rebelo AL, Chevalier MT, Russo L, Pandit A. Role and therapeutic implications of protein glycosylation in neuroinflammation. Trends Mol Med 2022:S1471-4914(22)00018-1. [PMID: 35120836 DOI: 10.1016/j.molmed.2022.01.004] [Reference Citation Analysis]
17 Agrati C, Sacchi A, Tartaglia E, Vergori A, Gagliardini R, Scarabello A, Bibas M. The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review. Int J Mol Sci 2021;22:7942. [PMID: 34360707 DOI: 10.3390/ijms22157942] [Reference Citation Analysis]
18 Kang J, Wu J, Liu Q, Wu X, Zhao Y, Ren J. Post-Translational Modifications of STING: A Potential Therapeutic Target. Front Immunol 2022;13:888147. [DOI: 10.3389/fimmu.2022.888147] [Reference Citation Analysis]
19 Zeng WF, Cao WQ, Liu MQ, He SM, Yang PY. Precise, fast and comprehensive analysis of intact glycopeptides and modified glycans with pGlyco3. Nat Methods 2021;18:1515-23. [PMID: 34824474 DOI: 10.1038/s41592-021-01306-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Pucci M, Malagolini N, Dall'Olio F. Glycobiology of the Epithelial to Mesenchymal Transition. Biomedicines 2021;9:770. [PMID: 34356834 DOI: 10.3390/biomedicines9070770] [Reference Citation Analysis]
21 Almahayni K, Spiekermann M, Fiore A, Yu G, Pedram K, Möckl L. Small molecule inhibitors of mammalian glycosylation. Matrix Biology Plus 2022. [DOI: 10.1016/j.mbplus.2022.100108] [Reference Citation Analysis]
22 Metcalf KJ, Hayward M, Berens E, Ironside AJ, Stashko C, Hwang ES, Weaver VM. Immunosuppressive glycoproteins associate with breast tumor fibrosis and aggression. Matrix Biology Plus 2022. [DOI: 10.1016/j.mbplus.2022.100105] [Reference Citation Analysis]
23 Xie X, Li J, Zhen X, Chen L, Yuan W, Feng Q, Liu X. Rational construction of fluorescent molecular imprinted polymers for highly efficient glycoprotein detection. Analytica Chimica Acta 2022;1209:339875. [DOI: 10.1016/j.aca.2022.339875] [Reference Citation Analysis]
24 Shanina E, Kuhaudomlarp S, Siebs E, Fuchsberger FF, Denis M, da Silva Figueiredo Celestino Gomes P, Clausen MH, Seeberger PH, Rognan D, Titz A, Imberty A, Rademacher C. Targeting undruggable carbohydrate recognition sites through focused fragment library design. Commun Chem 2022;5. [DOI: 10.1038/s42004-022-00679-3] [Reference Citation Analysis]
25 Cui T, Man Y, Wang F, Bi S, Lin L, Xie R. Glycoenzyme Tool Development: Principles, Screening Methods, and Recent Advances . Chin J Chem . [DOI: 10.1002/cjoc.202100770] [Reference Citation Analysis]
26 Paolillo M, Comincini S, Schinelli S. Fostering "Education": Do Extracellular Vesicles Exploit Their Own Delivery Code? Cells 2021;10:1741. [PMID: 34359911 DOI: 10.3390/cells10071741] [Reference Citation Analysis]
27 Takeda-uchimura Y, Nishitsuji K, Ikezaki M, Akama TO, Ihara Y, Allain F, Uchimura K. Beta3Gn-T7 Is a Keratan Sulfate β1,3 N-Acetylglucosaminyltransferase in the Adult Brain. Front Neuroanat 2022;16:813841. [DOI: 10.3389/fnana.2022.813841] [Reference Citation Analysis]
28 Ma W, Deng Y, Xu Z, Liu X, Chapla DG, Moremen KW, Wen L, Li T. Integrated Chemoenzymatic Approach to Streamline the Assembly of Complex Glycopeptides in the Liquid Phase. J Am Chem Soc 2022. [PMID: 35544340 DOI: 10.1021/jacs.2c01819] [Reference Citation Analysis]
29 Stewart N, Wisnovsky S. Bridging Glycomics and Genomics: New Uses of Functional Genetics in the Study of Cellular Glycosylation. Front Mol Biosci 2022;9:934584. [DOI: 10.3389/fmolb.2022.934584] [Reference Citation Analysis]
30 [DOI: 10.1101/2021.02.06.430063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Diniz F, Coelho P, Duarte HO, Sarmento B, Reis CA, Gomes J. Glycans as Targets for Drug Delivery in Cancer. Cancers 2022;14:911. [DOI: 10.3390/cancers14040911] [Reference Citation Analysis]
32 Hart DA. What Molecular Recognition Systems Do Mesenchymal Stem Cells/Medicinal Signaling Cells (MSC) Use to Facilitate Cell-Cell and Cell Matrix Interactions? A Review of Evidence and Options. Int J Mol Sci 2021;22:8637. [PMID: 34445341 DOI: 10.3390/ijms22168637] [Reference Citation Analysis]
33 Cao X, Du X, Jiao H, An Q, Chen R, Fang P, Wang J, Yu B. Carbohydrate-based drugs launched during 2000−2021. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.020] [Reference Citation Analysis]
34 Karmakar J, Mukherjee K, Mandal C. Siglecs Modulate Activities of Immune Cells Through Positive and Negative Regulation of ROS Generation. Front Immunol 2021;12:758588. [PMID: 34804046 DOI: 10.3389/fimmu.2021.758588] [Reference Citation Analysis]
35 Wang H, Zhang X, Peng Y, Pan B, Wang B, Haixiang Peng D, Guo W. The simultaneous profiling of 14 free monosaccharides in biofluids by a LC-MS/MS method. Journal of Chromatography B 2022. [DOI: 10.1016/j.jchromb.2021.123086] [Reference Citation Analysis]
36 Mijakovac A, Miškec K, Krištić J, Vičić Bočkor V, Tadić V, Bošković M, Lauc G, Zoldoš V, Vojta A. A Transient Expression System with Stably Integrated CRISPR-dCas9 Fusions for Regulation of Genes Involved in Immunoglobulin G Glycosylation. CRISPR J 2022. [PMID: 35021898 DOI: 10.1089/crispr.2021.0089] [Reference Citation Analysis]
37 Niu Y, Xue Q, Fu Y. Natural Glycan Derived Biomaterials for Inflammation Targeted Drug Delivery. Macromol Biosci 2021;:e2100162. [PMID: 34145960 DOI: 10.1002/mabi.202100162] [Reference Citation Analysis]
38 Boffoli D, Bellato F, Avancini G, Gurnani P, Yilmaz G, Romero M, Robertson S, Moret F, Sandrelli F, Caliceti P, Salmaso S, Cámara M, Mantovani G, Mastrotto F. Tobramycin-loaded complexes to prevent and disrupt Pseudomonas aeruginosa biofilms. Drug Deliv Transl Res 2021. [PMID: 34841492 DOI: 10.1007/s13346-021-01085-3] [Reference Citation Analysis]
39 Lünemann JD, von Gunten S, Neumann H. Targeting sialylation to treat central nervous system diseases. Trends Pharmacol Sci 2021;42:998-1008. [PMID: 34607695 DOI: 10.1016/j.tips.2021.09.002] [Reference Citation Analysis]
40 Zhou J, Wang L, Peng C, Peng F. Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology. Front Pharmacol 2022;13:886198. [DOI: 10.3389/fphar.2022.886198] [Reference Citation Analysis]
41 Saad AA. Targeting cancer-associated glycans as a therapeutic strategy in leukemia. All Life 2022;15:378-433. [DOI: 10.1080/26895293.2022.2049901] [Reference Citation Analysis]
42 Huwait E, Al-Saedi DA, Mirza Z. Anti-Inflammatory Potential of Fucoidan for Atherosclerosis: In Silico and In Vitro Studies in THP-1 Cells. Molecules 2022;27:3197. [PMID: 35630678 DOI: 10.3390/molecules27103197] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Richards SJ, Gibson MI. Toward Glycomaterials with Selectivity as Well as Affinity. JACS Au 2021;1:2089-99. [PMID: 34984416 DOI: 10.1021/jacsau.1c00352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Altmann S, Mut J, Wolf N, Meißner-Weigl J, Rudert M, Jakob F, Gutmann M, Lühmann T, Seibel J, Ebert R. Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides. Int J Mol Sci 2021;22:2820. [PMID: 33802220 DOI: 10.3390/ijms22062820] [Reference Citation Analysis]
45 Choi Y, Kim J, Chae J, Hong J, Park J, Jeong E, Kim H, Tanaka M, Okochi M, Choi J. Surface glycan targeting for cancer nano-immunotherapy. J Control Release 2022:S0168-3659(22)00004-9. [PMID: 34998918 DOI: 10.1016/j.jconrel.2022.01.004] [Reference Citation Analysis]
46 Hirani P, Gauthier V, Allen CE, Wight TN, Pearce OMT. Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer. Front Oncol 2021;11:712807. [PMID: 34527586 DOI: 10.3389/fonc.2021.712807] [Reference Citation Analysis]